Search Results for:
IBEC groups join forces to combat chronic bacterial infections
A study published today in the Journal of Controlled Release describes a new nanoparticle strategy able to target hard-to tackle infections caused by biofilm-forming bacteria.
Two IBEC groups have worked together to develop a new type of nanoparticle to help fight chronic illness caused by biofilm-forming bacteria.
Symposium TAU-IBEC
Nanobiotechnology and Nanomedicine: Moving forward the convergence between life sciences, medicine and engineering at the nanoscale
Symposium TAU-IBEC
Nanobiotechnology and Nanomedicine: Moving forward the convergence between life sciences, medicine and engineering at the nanoscale
6th European CellMech Meeting
13th – 15th May 2015 in Barcelona, hosted by the Institute for Bioengineering of Catalonia (IBEC)
6th European CellMech Meeting
13th – 15th May 2015 in Barcelona, hosted by the Institute for Bioengineering of Catalonia (IBEC)
Genetic “editing” a new tool to fight inherited disease
Researchers at the Hospital Clínic, IDIBAPS, the Hospital Sant Joan de Deu and the Institute for Bioengineering of Catalonia (IBEC) have participated in a study, led by Dr. Juan Carlos Izpisúa Belmonte of the Gene Expression Laboratory at California’s Salk Institute, that uses molecular “scissors” to remove mitochondrial mutations in mouse eggs.
For thousands of women worldwide who are carriers of a mitochondrial disease, having a healthy child can be a gamble.
PhD thesis defence: Teresa Galán
“Conducting Polymers for Nano and Micro Electrodes. Application to Biomolecule Sensing and Release”
PhD thesis defence: Teresa Galán
“Conducting Polymers for Nano and Micro Electrodes. Application to Biomolecule Sensing and Release”
IBEC receives Severo Ochoa Excellence Award
The Institute for Bioengineering of Catalonia is one of the two centres in Spain to be awarded accreditation in this round of the Severo Ochoa Excellence programme.
The Ministry for Economy and Competitiveness announced the provisional winners of the coveted distinction, selected by an international panel of more than 70 judges, this morning. Severo Ochoa Excellence Awards identify and promote research centres and units in Spain that stand out as international references in their specialized fields.
Researchers at the Hospital Clínic, IDIBAPS, the Hospital Sant Joan de Deu and the Institute for Bioengineering of Catalonia (IBEC) have participated in a study, led by Dr. Juan Carlos Izpisúa Belmonte of the Gene Expression Laboratory at California’s Salk Institute, that uses molecular “scissors” to remove mitochondrial mutations in mouse eggs.